1.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443
2.
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
by Palmer, Suetonia C, PhD
The Lancet (British edition), 2015, Vol.385 (9982), p.2047-2056
3.
Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
by Soliman, Elsayed Z., MD, MSc, MS
The American heart journal, 2010, Vol.159 (6), p.1102-1107
4.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis...
by Bakris, George L, Dr, Prof
The Lancet (British edition), 2010, Vol.375 (9721), p.1173-1181
5.
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
by Grinsztejn, Beatriz, MD
The Lancet infectious diseases, 2014, Vol.14 (4), p.281-290
6.
Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation
by Azmi, Shazli
Diabetologia, 2019-06-07, Vol.62 (8), p.1478-1487
7.
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection
by Hsu, Yao-Chun
Gut, 2015-03, Vol.64 (3), p.495-503
8.
Neuroendocrine Causes of Amenorrhea—An Update
by Fourman, Lindsay T
The journal of clinical endocrinology and metabolism, 2015-03, Vol.100 (3), p.812-824
9.
Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure
by Grassi, Guido
Hypertension (Dallas, Tex. 1979), 2011-04, Vol.57 (4), p.846-851
10.
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
by Group, Sharp Collaborative
The American heart journal, 2010, Vol.160 (5), p.785-794.e10
11.
Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease
by Moradi, Hamid
American journal of nephrology, 2013-08, Vol.38 (2), p.136-148
12.
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
by Targher, G
Diabetologia, 2010-04-06, Vol.53 (7), p.1341-1348
13.
Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
by Silverstein, Douglas M
Pediatric nephrology (Berlin, West), 2009-08-01, Vol.24 (8), p.1445-1452
14.
Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs
by Verheugt, Freek W A, Prof
The Lancet (British edition), 2015, Vol.386 (9990), p.303-310
15.
Arterial stiffness in chronic kidney disease: causes and consequences
by Chue, Colin D
Heart, 2010-06, Vol.96 (11), p.817-823
16.
Vitamin D Treatment and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
by Duranton, Flore
American journal of nephrology, 2013-04, Vol.37 (3), p.239-248
17.
Blood Pressure and Risk of All-Cause Mortality in Advanced Chronic Kidney Disease and Hemodialysis: The Chronic Renal Insufficiency Cohort Study
by Bansal, Nisha
Hypertension (Dallas, Tex. 1979), 2015-01, Vol.65 (1), p.93-100
18.
Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients
by Goodkin, David A
American journal of nephrology, 2013-11, Vol.38 (5), p.405-412
19.
Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis
by Van Der Meersch, Hans, M.D
The American heart journal, 2016, Vol.184, p.37-46
20.
Body composition and arterial stiffness in pediatric patients with chronic kidney disease
by Karava, Vasiliki
Pediatric nephrology (Berlin, West), 2019-03-29, Vol.34 (7), p.1253-1260
